EP3044222
ATRASENTAN MANDELATE SALTS FOR THE TREATMENT OF KIDNEY DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.9.2014EP published:
5.7.2017EP application number:
14780663.2
EPO information:
European Patent Register
Max expiry date:
9.9.2034
Title:
ATRASENTAN MANDELATE SALTS FOR THE TREATMENT OF KIDNEY DISEASES
Timeline
Today
10.9.2014EP application
5.7.2017EP Publication
Owner
Name:
Abbvie Inc.Address:
1 North Waukegan Road, 60064, North Chicago, IL, US
Inventor
Name:
GONG, YuchuanAddress:
Vernon Hills, Illinois, US
Name:
ZHANG, Geoff, G.Address:
Vernon Hills, Illinois, US
Priority
Number:
201361877101 PDate:
12.9.2013Country:
US
Number:
201314133297Date:
18.12.2013Country:
US
Classification
Categories:
C07D 405/04, A61K 31/4025, A61P 7/12